BIOMARKER:

Chr t(4;14)

Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	DVD Sensitive: B - Late Trials
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	daratumumab Sensitive: B - Late Trials
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	Isa-KRd Sensitive: C2 – Inclusion Criteria
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	lenalidomide + ixazomib Sensitive: C3 – Early Trials
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	Proteasome inhibitor + Immunomodulator Sensitive: C3 – Early Trials
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	bortezomib Resistant: C3 – Early Trials
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	midostaurin Sensitive: D – Preclinical
Chr t(4;14) Chr t(4;14)	Multiple Myeloma Multiple Myeloma	PFI-3 Sensitive: D – Preclinical

Associations